Risk-stratifying Jervell and Lange-Nielsen syndrome from clinical data

J Cardiovasc Electrophysiol. 2006 Nov;17(11):1169-71. doi: 10.1111/j.1540-8167.2006.00613.x. Epub 2006 Sep 20.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Defibrillators, Implantable
  • Humans
  • Jervell-Lange Nielsen Syndrome / mortality
  • Jervell-Lange Nielsen Syndrome / physiopathology*
  • Jervell-Lange Nielsen Syndrome / therapy*
  • Long QT Syndrome / mortality
  • Long QT Syndrome / physiopathology
  • Long QT Syndrome / therapy
  • Risk Factors

Substances

  • Adrenergic beta-Antagonists